Sinopharm Tech Holdings Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | no data |
| CEO ownership | n/a |
| Management average tenure | less than a year |
| Board average tenure | 2.4yrs |
Recent management updates
Recent updates
Is Sinopharm Tech Holdings Limited's (HKG:8156) Shareholder Ownership Skewed Towards Insiders?
Feb 02
How Much Did Sinopharm Tech Holdings'(HKG:8156) Shareholders Earn From Share Price Movements Over The Last Five Years?
Dec 29
How Should Investors Feel About Sinopharm Tech Holdings' (HKG:8156) CEO Remuneration?
Nov 24CEO
Sinopharm Tech Holdings has no CEO, or we have no data on them.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Director of Group Human Resources | no data | HK$904.00k | no data | |
| Co-Founder | no data | HK$20.00k | no data | |
| Director of Group Corporate Strategy & Investor Relations | no data | no data | no data | |
| General Counsel | 17.2yrs | no data | no data | |
| Executive Director | less than a year | no data | no data | |
| Company Secretary | less than a year | no data | no data |
Experienced Management: 8156's management team is not considered experienced ( 0.1 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Director of Group Human Resources | 2.8yrs | HK$904.00k | no data | |
| Executive Director | less than a year | no data | no data | |
| Independent Non-Executive Director | 1.8yrs | HK$48.00k | no data | |
| Independent Non-Executive Director | 5.5yrs | HK$78.00k | no data | |
| Non-Executive Director | 6yrs | HK$78.00k | 0.012% HK$ 16.5k | |
| Independent Non-Executive Director | 1.9yrs | HK$53.00k | no data |
Experienced Board: 8156's board of directors are not considered experienced ( 2.4 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/07/08 22:30 |
| End of Day Share Price | 2025/07/08 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Sinopharm Tech Holdings Limited is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Hoi Yin Yip | Everbright Securities International (HK) Limited (“EBSIHK”) |
| Hua He | Industrial Securities (HK) Financial Holdings |